Instrument Inactif

Gouvernance NeoGenomics, Inc. OTC Bulletin Board

US64049M2098

Installations et services en soins de santé

Cours en clôture OTC Bulletin Board Autres places de cotation
- ^USD	-

20/07	NeoGenomics conclut un accord avec le Département de la Justice concernant son programme de collaboration en laboratoire	MT
09/07	NeoGenomics lance le test compagnon PTEN IHC approuvé par la FDA pour le cancer de la prostate	CI

Comité Exécutif: NeoGenomics, Inc.

Dirigeant

Fonctions occupéesDepuis

Anthony Zook

65 ans

Chief Executive Officer

01/04/2025

Elizabeth Floegel

50 ans

Chief Tech/Sci/R&D Officer

Warren Stone

53 ans

Chief Operating Officer	01/04/2025
President	01/04/2025

Alicia Olivo

42 ans

General Counsel	01/08/2022
Corporate Secretary	01/08/2022

Gary Passman

Human Resources Officer

01/01/2023

Clarence Cooper

Compliance Officer

Gregory Aunan

56 ans

Comptroller/Controller/Auditor

Abhishek Jain

57 ans

Director of Finance/CFO

02/03/2026

Composition du Conseil d'Administration: NeoGenomics, Inc.

Administrateur

ComitésDepuis

Lynn Tetrault

64 ans

Compensation Committee	03/06/2025
Governance Committee	07/10/2021
Nominating Committee	07/10/2021
Compensation Committee Chair	09/12/2020

Michael Kelly

69 ans

Compensation Committee
Audit Committee Chair
Finance Committee Chair	15/07/2020
Governance Committee
Nominating Committee
Compensation Committee Chair	16/10/2024

David Perez

65 ans

Compensation Committee	01/09/2019
Audit Committee	03/11/2022
Finance Committee	03/11/2022
Compensation Committee Chair	03/11/2022

Felicia Williams

60 ans

Audit Committee	01/11/2024
Finance Committee	01/11/2024
Governance Committee	01/11/2024
Nominating Committee	01/11/2024

John Kenny

57 ans

Compensation Committee	28/10/2025
Governance Committee Chair	15/09/2023
Nominating Committee Chair	15/09/2023

Neil Gunn

65 ans

Compensation Committee
Governance Committee
Nominating Committee

Stephen Kanovsky

63 ans

Governance Committee Chair	19/07/2017
Nominating Committee Chair	19/07/2017

Anthony Zook

65 ans

Audit Committee

01/02/2025

Carolyn Starrett

Director/Board Member	23/06/2026
Independent Dir/Board Member	23/06/2026

Marjorie Green

Director/Board Member	19/06/2025
Independent Dir/Board Member	19/06/2025

Anciens Dirigeants et Administrateurs: NeoGenomics, Inc.

Insider

Fonctions occupées

DepuisJusqu'au

Jeffrey Sherman

Director of Finance/CFO	07/12/2022	02/03/2026
Investor Relations Contact	07/12/2022	-
Corporate Officer/Principal	02/03/2026	14/04/2026

Alison Hannah

Director/Board Member	12/06/2015	31/12/2025
Independent Dir/Board Member	-	31/12/2025

Hutan Hashemi

Compliance Officer

01/03/2022

01/12/2025

Melody Harris

Chief Operating Officer	15/04/2024	01/04/2025
Corporate Officer/Principal	05/12/2022	15/04/2024

Chris Smith

Director/Board Member	15/08/2022	01/04/2025
Chief Executive Officer	15/08/2022	01/04/2025

Shashikant Kulkarni

Chief Tech/Sci/R&D Officer

07/03/2022

01/06/2024

Bruce Crowther

Director/Board Member	22/10/2014	01/05/2024
Independent Dir/Board Member	-	01/05/2024

Vishal Sikri

Corporate Officer/Principal

23/05/2022

15/04/2024

Rachel Stahler

Director/Board Member	28/05/2020	26/06/2023
Independent Dir/Board Member	28/05/2020	26/06/2023

Kathryn McKenzie

Comptroller/Controller/Auditor	17/10/2017	05/02/2020
Director of Finance/CFO	05/02/2020	01/01/2022
Portfolio Manager-Fixed Income	01/01/2022	01/04/2023

David Daly

Director/Board Member	04/11/2021	19/01/2023
Independent Dir/Board Member	04/11/2021	19/01/2023

John Mooney

Chief Tech/Sci/R&D Officer

21/06/2021

02/01/2023

Marcus B. Silva

Sales & Marketing

01/06/2020

01/01/2023

Bill Bonello

Director of Finance/CFO	01/01/2022	05/12/2022
Investor Relations Contact	-	-
Corporate Officer/Principal	-	01/01/2022
Treasurer	20/04/2017	-

David Sholehvar

Chief Tech/Sci/R&D Officer

01/03/2021

01/11/2022

Charlie Christopher Eidson

Investor Relations Contact

01/09/2021

01/09/2022

Gina M. Wallar

Corporate Officer/Principal

01/12/2015

27/05/2022

Douglas M. Brown

Corporate Officer/Principal

01/02/2020

27/05/2022

Halley Gilbert

General Counsel

01/05/2022

George Cardoza

Director of Finance/CFO	07/12/2009	27/03/2018
Corporate Officer/Principal	27/03/2018	05/07/2021
President	05/07/2021	31/03/2022

Mark Mallon

Director/Board Member	19/04/2021	28/03/2022
Chief Executive Officer	19/04/2021	28/03/2022

Kevin Johnson

Director/Board Member	11/02/2011	17/01/2022
Independent Dir/Board Member	30/08/2012	17/01/2022

Jennifer M. Balliet

Human Resources Officer

01/01/2008

01/01/2022

Stephanie Bywater

Compliance Officer

01/05/2017

01/12/2021

Douglas van Oort

Director/Board Member	07/10/2021	04/11/2021
Chief Executive Officer	01/03/2009	19/04/2021
Chairman	01/03/2009	07/10/2021

Derek Lyle

Chief Tech/Sci/R&D Officer

01/07/2021

Forrest Holmes Blocker

Chief Tech/Sci/R&D Officer

01/06/2021

Denise Pedulla

General Counsel	01/01/2015	01/06/2021
Corporate Secretary	01/01/2015	01/06/2021

Steven Jones

Director/Board Member	01/10/2003	27/05/2021
Compliance Officer	07/02/2013	01/05/2018
Director of Finance/CFO	01/10/2003	01/11/2016
Independent Dir/Board Member	01/10/2003	27/05/2021
Investor Relations Contact	01/10/2003	-
Corporate Officer/Principal	01/01/2009	-

Raymond R. Hipp

Director/Board Member	11/02/2011	27/05/2021
Independent Dir/Board Member	03/02/2011	27/05/2021

Lawrence Weiss

Chief Tech/Sci/R&D Officer

13/12/2018

05/05/2021

Cynthia Dieter

Comptroller/Controller/Auditor

22/06/2020

Sharon A. Virag

Director of Finance/CFO

27/03/2018

08/08/2019

Maher Albitar

Chief Tech/Sci/R&D Officer

09/01/2012

01/10/2018

William J. Robison

Director/Board Member	30/05/2007	01/06/2018
Independent Dir/Board Member	30/05/2007	01/06/2018

John S. Park

Sales & Marketing

01/01/2018

Edwin Fred Weidig

Comptroller/Controller/Auditor	20/01/2012	17/10/2017
Corporate Secretary	-	-

Kieran Murphy

Director/Board Member	17/02/2016	19/07/2017
Independent Dir/Board Member	17/02/2016	19/07/2017

Christina Sun

Comptroller/Controller/Auditor

01/05/2017

Mark Machulcz

Chief Operating Officer	-	18/04/2017
Corporate Officer/Principal	28/01/2016	-

Robert H. Horel

Sales & Marketing

23/05/2011

01/10/2015

Steven Brodie

Chief Tech/Sci/R&D Officer	16/04/2015	-
Corporate Officer/Principal	-	-

Robert Shovlin

Chief Operating Officer	13/10/2014	-
Corporate Officer/Principal	-	-

Robert Gasparini

Director/Board Member	01/01/2004	04/08/2014
Chief Tech/Sci/R&D Officer	01/01/2004	04/08/2014
President	01/01/2004	04/08/2014

Steven Ross

Chief Tech/Sci/R&D Officer	22/04/2013	-
General Counsel	-	-

Peter Martin Peterson

Director/Board Member

22/06/2005

03/08/2012

Matthew William Moore

Chief Tech/Sci/R&D Officer

01/07/2006

31/03/2011

Mark W. Smits

Sales & Marketing

13/08/2010

01/03/2011

Marvin E. Jaffe

Director/Board Member

30/05/2007

03/02/2011

George O'Leary

Director/Board Member

01/10/2004

28/10/2010

Jack G. Spitz

Corporate Officer/Principal

16/12/2009

01/09/2010

Marydawn Miller

Chief Tech/Sci/R&D Officer

21/07/2010

Grant D. Carlson

Corporate Officer/Principal	13/08/2010	-
Sales & Marketing	31/07/2009	13/08/2010

Robert J. Feeney

Sales & Marketing

03/01/2007

Thomas D. Conrad

Director/Board Member

22/06/2005

05/09/2006

Jerome Dvonch

Comptroller/Controller/Auditor	01/08/2005	-
Director/Board Member	23/05/2011	-
Director of Finance/CFO	05/04/2010	25/02/2011

Thomas H. White

President

01/10/2003

Michael Dent

Director/Board Member	05/11/2009	-
Chairman	01/06/2001	05/11/2009
Founder	29/10/1998	-
Independent Dir/Board Member	29/10/1998	-

Alan Cotton

Corporate Officer/Principal

Distribution de l'Âge des Dirigeants

Parité Homme Femme

Homme	14
Femme	6

Dont comité exécutif

Homme	6
Femme	2

Dont Administrateurs

Homme	7
Femme	3

Révisions

Recommandations analystes

Évolution recommandations analystes 1 an

Évolution recommandations analystes 4 mois

Objectif analystes

Évolution objectif analystes 1 an

Évolution objectif analystes 4 mois

ESG MSCI

Environnement

Social

Gouvernance

Polémique

Controverses Ethiques

Non

Controverses sur les droits de l'Homme

Non

Controverses Subventions fiscales

Non

Conforme à la finance Islamique

NeoGenomics, Inc. est une société spécialisée dans le diagnostic du cancer, plus particulièrement dans les tests génétiques liés au cancer et les services d'information. La société propose une gamme complète de tests axés sur l'oncologie couvrant l'ensemble du spectre du cancer. Elle fournit aux oncologues, aux pathologistes, aux réseaux hospitaliers, aux centres universitaires et aux laboratoires pharmaceutiques des tests diagnostiques et prédictifs destinés à faciliter le diagnostic et le traitement du cancer. Ses services comprennent les tests cliniques du cancer, l'interprétation des résultats et les services de consultation, les tests moléculaires et de séquençage de nouvelle génération (NGS), une offre complète de services techniques et professionnels, les essais cliniques et la recherche, les services de laboratoires de validation, ainsi que des solutions de données en oncologie. Elle exploite un réseau de laboratoires proposant des services complets de traitement et d'analyse d'échantillons à travers les États-Unis, ainsi qu'un laboratoire de traitement d'échantillons offrant une gamme complète de services à Cambridge, au Royaume-Uni. Ses services de tests comprennent la cytogénétique, l'hybridation in situ en fluorescence (FISH), la cytométrie en flux, les tests moléculaires et d'autres techniques.

Employés

Secteur

Installations et services en soins de santé

Agenda

28/07 Publication des résultats - Q2 2026

Plus d'informations sur la société